Header Logo

Connection

Lisa Boggio to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Lisa Boggio has written about Antibodies, Monoclonal, Humanized.
Lisa Boggio
Connection Strength
0.052
Antibodies, Monoclonal, Humanized
  1. A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia. Br J Haematol. 2023 01; 200(2):229-239.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.